Bronchoscopy is introduction of an endoscope into the airways. Flexible fiberoptic bronchoscopy has replaced rigid bronchoscopy for virtually all diagnostic, and most therapeutic, indications.

Rigid bronchoscopy is now used only when a wider aperture and channels are required for better visualization and instrumentation such as when

• Investigating vigorous pulmonary hemorrhage (in which the rigid bronchoscope can better identify the bleeding source and, with its larger suction channel, can better suction the blood and prevent asphyxiation)
• Viewing and removing aspirated foreign bodies in young children
• Viewing obstructive endobronchial lesions (requiring laser debulking or stent placement)

Flexible bronchoscopes are nearly all color video–compatible, facilitating airway visualization and documentation of findings.

Diagnostically, flexible fiberoptic bronchoscopy allows for

• Direct airway visualization down to, and including, subsegmental bronchi
• Sampling of respiratory secretions and cells via bronchial washings, brushings, and lavage of peripheral airways and alveoli
• Biopsy of endobronchial, parenchymal, and mediastinal structures

Therapeutic uses include suctioning of retained secretions, endobronchial stent placement, and balloon dilation of airway stenoses.

Table 1
PrintOpen table in new window
Indications for Flexible Fiberoptic Bronchoscopy Procedure Indication Diagnostic Abnormal chest radiograph: To diagnosis the etiology of pneumonia*in an immunocompromised host; in a patient with hospital-acquired pneumonia; in an immunocompetent host with recurrent or nonresolving disease; or in a patient with a paratracheal/mediastinal/hilar mass, parenchymal mass or nodule, especially in proximal lung, or unexplained exudative pleural effusion Atelectasis (persistent)* Cough (persistent, unexplained)* Diffuse lung process (transbronchial lung biopsy) Evaluation for rejection in lung transplant recipient Evaluation of airway in burn patient Evaluation of chest trauma patient for bronchial disruption Hemoptysis Lung abscess in edentulous patient (suspect endobronchial lesion) Lung cancer staging Positive sputum cytology with normal chest x-ray* Suspected tracheoesophageal fistula Unexplained hoarseness or vocal cord paralysis Wheeze (localized/fixed) Therapeutic Aspiration of retained secretions* † Bronchopulmonary lavage (pulmonary alveolar proteinosis) Laser resection of tumor‡ Management of bronchopleural fistula Photodynamic therapy‡ Placement of airway stent‡ Placement of endotracheal tube in difficult patient (cervical injury, abnormal anatomy) Removal of foreign body‡ *Flexible fiberoptic bronchoscopy is indicated only after failure of less invasive investigations and treatments. †Flexible fiberoptic bronchoscopy is not a substitute for chest physiotherapy, bronchodilator nebulization, and nasotracheal suctioning; it should be reserved for hypoxemia (in a ventilated patient) and/or lobar atelectasis secondary to impacted secretions refractory to conventional therapy. ‡Rigid bronchoscopy provides more control for instrumentation than flexible bronchoscopy and may be helpful.

Contraindications: Absolute contraindications include

• Untreatable life-threatening arrhythmias
• Inability to adequately oxygenate the patient during the procedure
• Acute respiratory failure with hypercapnia (unless the patient is intubated and ventilated)

Relative contraindications include

• Uncooperative patient
• Recent MI
• High-grade tracheal obstruction
• Uncorrectable coagulopathy

Transbronchial biopsy should be done with caution in patients with uremia, superior vena cava obstruction, or pulmonary hypertension because of increased risk of bleeding. Inspection of the airways is safe in these patients, however.

Procedure: Bronchoscopy should be done only by a pulmonologist or trained surgeon in a monitored setting, typically a bronchoscopy suite, operating room, or ICU (for ventilated patients).

Patients should receive nothing by mouth for at least 4 h before bronchoscopy and have IV access, intermittent BP monitoring, continuous pulse oximetry, and cardiac monitoring. Supplemental O₂ should be available. Premedication with atropineSome Trade Names
ATROPEN
ATROPINE-CARE
SAL-TROPINE
Click for Drug Monograph
0.01 mg/kg IM or IV to decrease secretions and vagal tone is common, although this practice has been called into question by recent studies. Short-acting benzodiazepines, opioids, or both are generally given to patients before the procedure to decrease anxiety, discomfort, and cough.

The pharynx and vocal cords are anesthetized with nebulized or aerosolized lidocaineSome Trade Names
XYLOCAINE
Click for Drug Monograph
(1 or 2%, to a maximum of 250 to 300 mg for a 70-kg patient). The bronchoscope is lubricated with lidocaineSome Trade Names
XYLOCAINE
Click for Drug Monograph
jelly and passed through the nostril or through the mouth with use of an oral airway or bite block. After inspecting the nasopharynx and larynx, the clinician passes the bronchoscope through the vocal cords during inspiration, into the trachea and then further distally into the bronchi.

Several ancillary procedures can be done as needed, with or without fluoroscopic guidance:

• Bronchial washing: Saline is injected through the bronchoscope and subsequently aspirated from the airways.
• Bronchial brushing: A brush is advanced through the bronchoscope and used to abrade suspicious lesions to obtain cells.
• Bronchoalveolar lavage: 50 to 200 mL of sterile saline is infused into the distal bronchoalveolar tree and subsequently suctioned out, retrieving cells, protein, and microorganisms located at the alveolar level. Local areas of pulmonary edema created by lavage may cause transient hypoxemia.
• Transbronchial biopsy: Forceps are advanced through the bronchoscope and airway to obtain samples from one or more sites in the lung parenchyma. Transbronchial biopsy can be done without x-ray guidance, but evidence supports increased diagnostic yields and lower incidence of pneumothorax when fluoroscopic guidance is used.
• Transbronchial needle aspiration: A retractable needle is inserted through the bronchoscope and can be used to sample enlarged mediastinal lymph nodes or masses.

Patients are typically given supplemental O₂ and observed for 2 to 4 h after the procedure. Return of a gag reflex and maintenance of O₂ saturation when not receiving O₂ are the two primary indices of recovery. Standard practice is to obtain a posteroanterior chest x-ray after transbronchial lung biopsy to exclude pneumothorax.

Complications: Serious complications are uncommon; minor bleeding from a biopsy site and fever occur in 10 to 15% of patients. Premedication can cause oversedation with respiratory depression, hypotension, and cardiac arrhythmias. Rarely, topical anesthesia causes laryngospasm, bronchospasm, seizures, methemoglobinemia with refractory cyanosis, or cardiac arrhythmias or arrest.

Bronchoscopy itself may cause minor laryngeal edema or injury with hoarseness, hypoxemia in patients with compromised gas exchange, arrhythmias (most commonly premature atrial contractions, ventricular premature beats, or bradycardia), and, very rarely, transmission of infection from suboptimally sterilized equipment. Mortality is 1 to 4/10,000 patients. The elderly and patients with serious comorbidities (severe COPD, coronary artery disease, pneumonia with hypoxemia, advanced cancers, mental dysfunction) are at greatest risk.

Transbronchial biopsy can cause pneumothorax (2 to 5%) and significant hemorrhage (1 to 1.5%); mortality increases to 12/10,000 patients, but doing the procedure can avoid the need for thoracotomy.

Last full review/revision June 2009 by Noah Lechtzin, MD, MHS

Content last modified February 2012